A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

Investigational Site Number : 1240003, Calgary, Alberta, Canada

Investigational Site Number : 1240002, Surrey, British Columbia, Canada

Investigational Site Number : 1240001, Sherbrooke, Quebec, Canada

Investigational Site Number : 2760002, Essen, Germany

Investigational Site Number : 2760001, Frankfurt, Germany

Investigational Site Number : 3800005, Merano, Bolzano / Bozen, Italy

Investigational Site Number : 3800001, Milan, Milano, Italy

Investigational Site Number : 3800004, Milan, Milano, Italy

Investigational Site Number : 3800003, Palermo, Italy

Investigational Site Number : 3800002, Pisa, Italy

Investigational Site Number : 7240002, Barcelona, Catalunya [Cataluña], Spain

Investigational Site Number : 7240001, Pamplona, Navarre, Spain

Investigational Site Number : 7240004, Seville, Sevilla, Spain

Investigational Site Number : 8260003, Milton Keynes, Buckinghamshire, United Kingdom

Investigational Site Number : 8260001, Newcastle upon Tyne, England, United Kingdom